NASDAQ:EVGN - Evogene SEC Filings & 10K Form

$1.61
-0.02 (-1.23 %)
(As of 09/15/2019 02:35 AM ET)
Today's Range
$1.57
Now: $1.61
$1.63
50-Day Range
$1.34
MA: $1.57
$1.71
52-Week Range
$1.34
Now: $1.61
$3.32
Volume7,340 shs
Average Volume10,281 shs
Market Capitalization$41.46 million
P/E RatioN/A
Dividend YieldN/A
Beta1.16

SEC Filings

Evogene (NASDAQ:EVGN) SEC Filings

DateFilerForm TypeView
08/22/2019
9:30 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2019
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2019
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2019
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2019
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2019
6:02 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2019
9:31 AM
Evogene (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/15/2019
5:12 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2019
3:37 PM
Evogene (Subject)
Senvest Management, LLC (Filed by)
Form SC 13G
04/03/2019
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2019
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2019
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2019
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2019
1:16 PM
Evogene (Subject)
UBS Group AG (Filed by)
Form SC 13G/A
02/14/2019
11:45 AM
Evogene (Subject)
Phoenix Holdings Ltd. (Filed by)
Form SC 13G/A
02/14/2019
5:20 AM
Evogene (Subject)
Migdal Insurance & Financial Holdings Ltd. (Filed by)
Form SC 13G
02/12/2019
9:36 AM
Evogene (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
02/04/2019
6:02 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2019
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/29/2019
1:44 PM
Evogene (Subject)
Harel Insurance Investments & Financial Services Ltd. (Filed by)
Form SC 13G/A
11/27/2018
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/19/2018
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2018
6:01 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2018
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2018
6:03 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2018
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2018
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/14/2018
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2018
6:01 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2018
5:16 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2018
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2018
5:14 AM
Evogene (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/28/2018
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2018
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2018
5:11 AM
Evogene (Subject)
Phoenix Holdings Ltd. (Filed by)
Form SC 13G/A
02/14/2018
3:10 PM
Evogene (Subject)
WADDELL & REED FINANCIAL INC (Filed by)
Form SC 13G/A
02/13/2018
3:43 PM
Evogene (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G
02/13/2018
2:38 PM
Evogene (Subject)
UBS Group AG (Filed by)
Form SC 13G
02/12/2018
2:31 PM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2018
2:17 PM
Evogene (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G
02/12/2018
6:07 AM
Evogene (Subject)
Psagot Investment House Ltd. (Filed by)
Form SC 13G/A
02/01/2018
5:44 AM
Evogene (Subject)
Harel Insurance Investments & Financial Services Ltd. (Filed by)
Form SC 13G/A
01/22/2018
5:32 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2018
5:31 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2018
5:12 AM
Evogene (Subject)
Migdal Insurance & Financial Holdings Ltd. (Filed by)
Form SC 13G
This page was last updated on 9/15/2019 by MarketBeat.com Staff

Featured Article: Trade Deficit

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel